Bayer announced today that the U.S. Food and Drug Administration (FDA) approved Kyleena (levonorgestrel-releasing intrauterine system) 19.5 mg, a progestin-containing intrauterine system (IUS), for the prevention of pregnancy for up to five years.1Kyleena will be available by prescription only in October 2016. “Data show that the use of effective, long-acting birth control methods including intrauterine[…]